Name2

　　Liaoning Chaohua Pharmaceutical (Group) Co., Ltd. was founded in 1967 and was established as a joint-stock enterprise on the basis of Liaoning Chaohua Pharmaceutical Co., Ltd., marking 56 years of development to date. The company holds 80 drug approval numbers, including two nationally exclusive products: “Shanpu Jianpi Granules” and “Niuhuang Qingfei Tablets.” The company is positioned to take Chaohua Pharmaceutical as its leading entity, extend and strengthen the industrial value chain, and establish seven major business segments: an R&D center, a testing and inspection center, pharmaceutical manufacturing, an alliance for the cultivation of Chinese medicinal materials and food ingredients, a marketing center, a research-and-learning base, and an integrated medical-care-and-elderly-care platform. These initiatives are designed to drive high-quality corporate development, vigorously advance the rural revitalization initiative through traditional Chinese medicine, and leverage the company’s strengths as a leading industry player and a high-tech enterprise to accelerate the diversified, urban–rural integrated development of the TCM industry.

　　Liaoning Chaohua Pharmaceutical Group is fully leveraging the enterprise’s strengths to seamlessly integrate front-end product R&D, the cultivation and production of medicinal herbs and food ingredients, the development of new business models, quality inspection and testing, and the online–offline sales of finished products and intermediates. In particular, the group is scaling up and optimizing the production of traditional Chinese medicines, health foods derived from medicinal herbs, seasonings, and intermediate products for animal feed and animal-based foods, thereby further absorbing local and surrounding-area Chinese herbal resources, promoting the restructuring of traditional agricultural practices, and focusing on the overarching goal of building “Digital Chaoyang and a Smart Manufacturing Powerhouse.” This initiative aims to lead the high-quality development of Chaoyang’s TCM industry while using industrial revitalization as a key lever to effectively align the group’s end-to-end value-chain advantages with rural revitalization efforts. By establishing an effective mechanism that links TCM-related industries with rural revitalization and benefits farmers, the group seeks to drive common prosperity for rural communities.